Bernese periacetabular osteotomy (PAO) has been shown to be applicable as a hip-preserving technique for the treatment of developmental dysplasia of the hip (DDH). The approach could be designed preoperatively using various types of reverse-engineering software and finite element analysis, but how to implement it in the actual PAO remains a challenge. This study examines and evaluates a solution to achieve higher accuracy when performing a PAO. A patient-specific cutting and rotating template was predesigned through computer-aided design (CAD) with three-dimensional (3D) modeling programs. The templates were then reproduced with rapid prototyping (RP) technology and used in the actual PAO. Finally, the clinical and radiographic effects were assessed and compared between the newly developed PAO and conventional PAO groups. The customized cutting template fit well with the bone surface and served as a guide for surgeons as they slid the osteotome to the precise location that had been determined prior to surgery. A very similar acetabular fragment was reproduced, and no major complications occurred when performing the osteotomy along the edge of the cutting template. The acetabular fragment was then corrected to the predetermined position through one-off manipulation with the customized rotating template. The final position of the acetabular fragment in the new developed PAO group was highly consistent with the planned position, and the postoperative morphological parameters were consistent with the preoperative planned data compared to the conventional PAO group. The duration of the operation and the number of irradiation decreased significantly. The Harris hip score (HHS) and visual analogue scale (VAS) score improved significantly with the use of the new developed PAO. We demonstrate that our system, which was based on CAD-RP technology, is feasible and could realize the predicted results accurately during the actual PAO.
4 October 2016 in Journal of Orthopaedic Surgery and Research
The success of Bernese periacetabular osteotomy depends significantly on how extent the acetabular fragment can be corrected to its optimal position. This study was undertaken to investigate whether correcting the acetabular fragment into the so-called radiological “normal” range is the best choice for all developmental dysplasia of the hip with different severities of dysplasia from the biomechanical view? If not, is there any correlation between the biomechanically optimal position of the acetabular fragment and the severity of dysplasia? Four finite element models with different severities of dysplasia were developed. The virtual periacetabular osteotomy was performed with the acetabular fragment rotated anterolaterally to incremental center-edge angles; then, the contact area and pressure and von Mises stress in the cartilage were calculated at different correction angles. The optimal position of the acetabular fragment for patients 1, 2, and 3 was when the acetabular fragment rotated 17° laterally (with the lateral center-edge angle of 36° and anterior center-edge angle of 58°; both were slightly larger than the “normal” range), 25° laterally following further 5° anterior rotation (with the lateral center-edge angle of 31° and anterior center-edge angle of 51°; both were within the “normal” range), and 30° laterally following further 10° anterior rotation (with the lateral center-edge angle of 25° and anterior center-edge angle of 40°; both were less than the “normal” range), respectively. The optimal corrective position of the acetabular fragment is severity dependent rather than within the radiological “normal” range for developmental dysplasia of the hip. We prudently proposed that the optimal correction center-edge angle of mild, moderate, and severe developmental dysplasia of the hip is slightly larger than the “normal” range, within the “normal” range, and less than the lower limit of the “normal” range, respectively.
Study Design.: Preclinical experimental study. Objective.: To explore the use of hydrogels as bioactive scaffolds for encapsulating bone marrow mesenchymal stem cells (BMSCs) to enhance their therapeutic potential in spinal cord injury (SCI). This study further aims to evaluate the added value of a BMP7 nanoparticle delivery system in overcoming the limitations of BMSCs alone for SCI repair. Summary of Background Data.: SCI leads to significant neuron loss and functional impairment. Although BMSC-based stem cell therapies show promise, their efficacy is limited by challenges such as the instability of bone morphogenetic protein (BMP)-7 in inducing neuronal differentiation. High concentrations of BMP7, although effective in promoting neuronal differentiation, may cause inflammation, necessitating the development of a delivery system for sustained and localized release. Methods.: BMSCs were isolated from Sprague-Dawley rats, and BMP-7’s effects on neuronal differentiation were assessed through western blotting. BMP7-loaded nanoparticles (NPs) and BMSCs were co-loaded into a gelatin methacrylate (Gel-MA) hydrogel scaffold, with a cell loading density of 1 × 105 cells/μl. BMP7 was encapsulated at a 0.04% (w/V) concentration, corresponding to approximately 0.4 ng BMP7 per μl of hydrogel. Optimization was performed using mechanical, cytotoxicity, and neuronal marker analyses. Scaffold properties, including water absorption, BMP7 release, and BMSC morphology, were characterized. Therapeutic efficacy was evaluated in a rat SCI model using motor function recovery, histologic analysis, and molecular assessments. Results.: BMP-7 effectively promoted BMSC differentiation into neurons while suppressing glial cell development. The BMP7-NPs/Gel-MA scaffold ensured sustained BMP7 release, achieving optimal differentiation at a 0.04% (w/V) BMP7 concentration. In vivo, the scaffold combined with BMSCs enhanced neuronal proliferation and differentiation, stimulated myelin regeneration, reduced lesion volume, and significantly improved motor function recovery. Conclusion.: The BMP7-NPs/Gel-MA scaffold provides sustained delivery of BMP-7, effectively directing BMSC differentiation into neuron-like cells while avoiding glial commitment. Combined with BMSCs, it offers a promising therapeutic strategy for SCI repair.
7 December 2025 in Journal of Orthopaedic Surgery and Research
Background: The proliferation, migration, and osteogenic differentiation of bone mesenchymal stem cells (BMSCs) play vital roles in maintaining bone mass and metabolism. BMSC base cell therapy has become a competitive treatment option for osteoporosis. PIWI-interacting RNAs (piRNAs) are critical regulators of cellular processes. Methods: Small RNA sequencing and qPCR were used to detect piRNA expression during BMSC proliferation. CCK-8, clone formation, and EdU assays were used to detect the effect of piRNA DQ690018 on BMSC proliferation. Wound healing and Transwell assays were used to assess the effect of piRNA DQ690018 on the migration of BMSCs. RNA sequencing was performed to identify DQ690018. Alkaline phosphatase and alizarin red staining were used to evaluate the effect of DQ690018 on osteogenic differentiation.The glucocorticoid-induced osteoporosis animal model was used to assess the impact of DQ690018 on bone mass. Micro-CT and hematoxylin and eosin staining of tibia were used to measure bone mass. Results: Fifteen piRNAs were upregulated, and 81 piRNAs were downregulated during BMSC proliferation. DQ690018 promotes BMSC proliferation by downregulating p21 expression and BMSC migration by upregulating vinculin (Vcl) expression. Furthermore, it improved the osteogenic differentiation of BMSCs and promoted the effect of BMSC base cell therapy in maintaining bone mass. Conclusion: DQ690018 is a novel target for increasing the proliferation, migration, and osteogenic differentiation of BMSCs.